Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.0%

78 terminated/withdrawn out of 970 trials

Success Rate

87.3%

+0.8% vs industry average

Late-Stage Pipeline

6%

58 trials in Phase 3/4

Results Transparency

3%

18 of 538 completed trials have results

Key Signals

143 recruiting18 with results63 terminated15 withdrawn

Enrollment Performance

Analytics

N/A
410(70.2%)
Phase 2
74(12.7%)
Phase 3
40(6.8%)
Phase 1
40(6.8%)
Phase 4
18(3.1%)
Early Phase 1
2(0.3%)
584Total
N/A(410)
Phase 2(74)
Phase 3(40)
Phase 1(40)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (970)

Showing 20 of 970 trials
NCT06893757Recruiting

Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)

Role: collaborator

NCT02040363Not ApplicableCompleted

Muscle Training Induced Angiogenesis in COPD

Role: collaborator

NCT02838069Phase 2Completed

A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis

Role: collaborator

NCT07644715Recruiting

AI-powered ECG Analysis for Deadly Arrhythmias and ICI Myocarditis

Role: collaborator

NCT07539207Not ApplicableNot Yet Recruiting

Precarity and Reduction of Its Impact on the Mental Health of Health Students

Role: lead

NCT01882062Phase 2Completed

Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease

Role: lead

NCT03311152Not ApplicableCompleted

Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis

Role: collaborator

NCT02556489Completed

Transcriptomics Signature of Anti Vaccinia Memory B Cells

Role: lead

NCT07604922Not ApplicableNot Yet Recruiting

Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease

Role: lead

NCT04051970Phase 3Terminated

Reducing Antiretroviral Treatments

Role: collaborator

NCT05336604Completed

STUDY OF THE COVID-19 EPIDEMIC AND SOCIO-ECONOMIC LIVING CONDITIONS IN FRANCE

Role: lead

NCT01579409Phase 4Completed

Impact of Dietary Status on Vascular Function Before and After a Standardized Breakfast. An "Exposed/Unexposed" Study Embedded in the SUVIMAX2 Cohort

Role: lead

NCT01842919Not ApplicableCompleted

Dance and Huntington Disease

Role: lead

NCT06951035Not ApplicableRecruiting

Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke

Role: lead

NCT07071259Not ApplicableNot Yet Recruiting

Study of the Correlation Between Cortical Excitability and Cytoarchitectonics of Prefrontal Cortex in Healthy Adult Participants, Using Transcranial Magnetic Stimulation Coupled to EEG and High-field MRI

Role: lead

NCT06701851Not ApplicableRecruiting

Neural Correlates of Movement Disorders Associated With PRRT2 Related Paroxysmal Kinesigenic Dyskinesia - an Ancillary Study of AMEDYST Research

Role: lead

NCT04532944Not ApplicableCompleted

The Energetic Origin of Neurodegeneration in MS

Role: lead

NCT05328024Recruiting

Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma

Role: collaborator

NCT03381950Completed

Chronic Kidney Disease - Renal Epidemiology and Information Network

Role: lead

NCT07599449Not Yet Recruiting

Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France

Role: lead